Subpart D. Subpart D—Additional Submission of Clinical Trial Information

• § 11.60 - What requirements apply to the voluntary submission of clinical trial information for clinical trials of FDA-regulated drug products (including biological products) and device products?
• § 11.62 - What requirements apply to applicable clinical trials for which submission of clinical trial information has been determined by the Director to be necessary to protect the public health?
• § 11.64 - When must clinical trial information submitted to ClinicalTrials.gov be updated or corrected?